West Bengal Governor CV Ananda Bose discharged after 23-day hospital stay, advised to slow work pace
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Kolkata: West Bengal Governor CV Ananda Bose was discharged from the hospital after 23 days after undergoing intervention procedure, people in the know said.He was admitted to a hospital with complaints of shoulder pain , following his visit to communal violence-hit Murshidabad and Malda. Raj Bhawan has confirmed about the release of Bose from the hospital and noted that 'he is now in good health.''We are pleased to inform that the Honourable Governor of West Bengal Dr C V Ananda Bose has returned to Raj Bhavan after a brief period of medical care and rest at the hospital. We are happy to share that the Honourable Governor is now in good health and high spirits,' Raj Bhawan source said.Bose was discharged from the Kolkata-based private hospital nearly three weeks after he was admitted there on April 22 with shoulder pain.'Dr CV Ananda Bose, Hon'ble Governor of West Bengal, was brought to Apollo Multispeciality Hospitals , Kolkata, on April 22, 2025, with complaint of shoulder pain after his hectic work during his visit to the field,' the hospital said in a press statement.The hospital authority said also confirmed that 'On detailed examination, he was found to have mild coronary artery disease . He underwent an intervention procedure.''He has been cooperative and responded well to the treatment and has been discharged from the hospital on May 15, 2025. Now his oxygen saturation is 100%, his blood pressure and blood glucose level are normal. However, he has been advised by the medical team to slow down his pace of work until the next assessment,' the statement said.On April 21, Bose was rushed to Kolkata's Eastern Command Army Hospital when he complained of uneasiness following his return from communal violence-hit areas in Murshidabad district.The Governor was reportedly shifted to the private hospital the next day , where he was treated, till his discharge. West Bengal Chief Minister Mamata Banerjee visited him at both the hospitals.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
4 hours ago
- New Indian Express
Health department seeks probe into ‘unethical' clinical trials at HCG
BENGALURU: The Health and Family Welfare Department has written to the Drug Controller General of India (DCGI), seeking an investigation into alleged unethical clinical trials at Bengaluru-based HCG Hospital, a well-known cancer care hospital chain. The department acted after Justice P Krishna Bhat, former chairperson of the Institutional Ethics Committee (IEC) at HCG, raised serious concerns and resigned earlier this year. His resignation followed complaints about how clinical trials were being handled, especially patient safety, ethical violations and conflicts of interest. In a letter dated June 30, the health commissioner noted that the allegations raised questions about compliance with rules and integrity of clinical research. 'These lapses, if proven, will undermine the strict ethical principles laid down by DGCI, ICMR, DHR, and bodies like WHO,' the commissioner said. Justice Bhat had written on March 5 outlining several concerns. One of the main issues was a conflict of interest — Dr Sathish, director of clinical trials at HCG, was also acting as principal investigator (PI) or co-PI in many of the clinical trials he was supposed to oversee. This, according to medical research rules, is not allowed. ICMR states members of an ethics committee should not act as investigators in the same studies, as it affects independent judgement and patient safety.
Indian Express
5 hours ago
- Indian Express
Fake Dr John Camm case exposed police failures, NHRC says
In its report on the case of a fake cardiologist, who practised in Madhya Pradesh and other parts of India after falsely taking the identity of UK-based Dr N John Camm, the National Human Rights Commission (NHRC) has criticised the police investigation, finding 'several discrepancies' and inadequate charges filed against those responsible for seven patient deaths. The NHRC report, submitted on July 1, said: 'The present case is connected with deaths of victims during treatment provided by the alleged fake doctors. The police have registered the FIR under sections of IPC which prescribe much lesser punishment, whereas allegations pertain to homicide, cheating, forgery etc.' The accused, Narendra Vikramaditya Yadav, was later arrested from Uttar Pradesh in April and is currently under judicial custody. The NHRC criticised the police investigation, saying that 'the police failed to take cognisance of the fact that the present FIR pertains to treatment given by a fake doctor, not medical negligence. The police should have initiated the investigation rather to wait for the inquiry report.' The commission said, 'The submission of questionable documents, absence of a verifiable qualification/license and permitting an unqualified person to not only practise as a doctor but also to perform life-threatening critical surgeries are wilful negligence and severe breach of statutory duties by CMHO, Damoh (the Chief Medical and Health Officer of Madhya Pradesh's Damoh district).' The report revealed that Yadav had falsely claimed to be an alumnus of North Bengal Medical College, and that the institution had denied this claim. The NHRC report also alleged that the management of the Damoh hospital where he worked had engaged in fraudulent activities for years without proper oversight. 'The accused was running the hospital since several years. However, it is evident that no effort was taken by the CMHO, Damoh, to verify the degree and registration of the doctors and the establishment. Apparently, no inspection was carried out prior to the filing of the present complaint,' the report said. The hospital also allegedly misused the credentials of another doctor, Dr Akhilesh Dubey, to fraudulently obtain a license for its Cath Lab without his consent, the report said. According to the commission's findings, 'Dr Akhilesh Dubey informed that he had been providing Super Specialist OPD at Mission Hospital, Damoh, once in a month for the last 3 to 5 years and Mission Hospital runs a Cath Lab at Damoh. However, he has no relation with the Cath Lab of Mission Hospital.' The report also alleged serious irregularities in the implementation of the Ayushman Bharat government-sponsored health insurance scheme at the hospital. It said the hospital 'systematically misused the scheme by issuing fraudulent bills for treatments'. Families of patients were allegedly compelled to pay substantial amounts despite having Ayushman Bharat cards. The report said, 'In several cases, patient was allegedly compelled to pay Rs 2,15,000 (to) Rs 2,80,000 for an angiography and other procedures, and even the Ayushman Bharat card was taken at the time of admission, however, no money or very less money was refunded back to the family members.' The NHRC has directed the Madhya Pradesh government to file separate FIRs and provide compensation to the families of those who died allegedly after being treated by the fake cardiologist.
Time of India
6 hours ago
- Time of India
FDA issues highest-level recall for Alma Pak organic blueberries over Listeria contamination
The FDA has issued a Class I recall for Alma Pak International LLC's organic blueberries after Listeria monocytogenes was detected. This recall affects 400 boxes distributed to North Carolina. Listeria infection poses a severe risk, especially to vulnerable populations, potentially leading to serious illness or death. Consumers are urged to check lot numbers and seek medical attention if symptoms arise. Tired of too many ads? Remove Ads What's affected? Product: Organic blueberries from Alma Pak International LLC (Georgia-based) Quantity: 400 boxes, each weighing 30 pounds (totaling 12,000 pounds) Lot Numbers: 13325 G1060 and 13325 G1096 Distribution: Shipped to a single customer in North Carolina Why the urgency? Check their blueberries for the affected lot numbers Avoid consuming any recalled product Contact the retailer for a refund Seek medical attention if symptoms of listeriosis develop after consumption Company response and background Tired of too many ads? Remove Ads The U.S. Food and Drug Administration (FDA) has issued a Class I recall—the highest possible risk level—for 400 boxes of organic blueberries distributed by Alma Pak International LLC, following the detection of Listeria monocytogenes during routine testing. The recall, first initiated on June 9, 2025, was elevated to Class I status on July 1, signaling a 'reasonable probability' that consuming the affected product could lead to serious health consequences or even death, according to the FDA's official monocytogenes is a dangerous bacteria that can contaminate various foods. Infection, known as listeriosis, is particularly hazardous for newborns, adults over 65, and individuals with weakened immune systems. Symptoms range from fever, muscle aches, nausea, vomiting, and diarrhea in milder cases, to severe complications such as headaches, neck stiffness, confusion, loss of coordination, and seizures in more vulnerable individuals. Listeria infection is the third leading cause of death from foodborne illness in the U.S., causing around 260 deaths are urged to:The FDA's Class I recall status underscores the seriousness of this contamination, as the agency warns that exposure to the tainted blueberries could result in life-threatening Pak International LLC has voluntarily recalled the product and is cooperating with authorities. Notably, this is not the company's first recall—previous incidents have included recalls for other frozen berry products due to contamination recall comes amid a broader trend of increased food recalls in 2024 and 2025, with a notable rise in hospitalizations and deaths linked to foodborne you have purchased Alma Pak organic blueberries, check your packaging immediately and follow FDA guidance to ensure your safety.
